Authors:
SPENGLER M
REICHERTL H
FURUKUBOTOKUNAGA K
Citation: M. Spengler et al., GENETICS OF ADULT BRAIN-DEVELOPMENT OF DROSOPHILA - GAL-4 MUTAGENESIS, European journal of neuroscience, 10, 1998, pp. 2607-2607
Authors:
FISCHER S
HANEFELD M
SPENGLER M
BOEHME K
TEMELKOVAKURKTSCHIEV T
Citation: S. Fischer et al., EUROPEAN STUDY ON DOSE-RESPONSE RELATIONSHIP OF ACARBOSE AS A FIRST-LINE DRUG IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - EFFICACY AND SAFETY OF LOW AND HIGH-DOSES, Acta diabetologica, 35(1), 1998, pp. 34-40
Authors:
WALLSCHLAGER D
DESAI MVM
SPENGLER M
WILKEN RD
Citation: D. Wallschlager et al., MERCURY SPECIATION IN FLOODPLAIN SOILS AND SEDIMENTS ALONG A CONTAMINATED RIVER TRANSECT, Journal of environmental quality, 27(5), 1998, pp. 1034-1044
Authors:
WALLSCHLAGER D
DESAI MVM
SPENGLER M
WINDMOLLER CC
WILKEN RD
Citation: D. Wallschlager et al., HOW HUMIC SUBSTANCES DOMINATE MERCURY GEOCHEMISTRY IN CONTAMINATED FLOODPLAIN SOILS AND SEDIMENTS, Journal of environmental quality, 27(5), 1998, pp. 1044-1054
Authors:
FISCHER S
HANEFELD M
KOHLER C
SPENGLER M
HEYEN P
FUCKER K
MENSCHIKOWSKI M
Citation: S. Fischer et al., COMPARATIVE INVESTIGATIONS OF THE EFFECTS OF GLIBENCLAMIDE AND ACARBOSE ON CIRCADIAN INSULIN LEVELS IN NIDDM, Diabetologia, 40, 1997, pp. 1256-1256
Citation: M. Hopfner et al., THE BLOOD-GLUCOSE LOWERING EFFECT OF ACARBOSE IS NOT INFLUENCED BY A SIMULTANEOUS THERAPY WITH MALLOX(R)70, Diabetologia, 40, 1997, pp. 1279-1279
Citation: M. Hopfner et al., THE BLOOD-GLUCOSE LOWERING EFFECT OF ACARBOSE IS NOT INFLUENCED BY A SIMULTANEOUS THERAPY WITH MAALOX(R)70, Diabetes, 46, 1997, pp. 1268-1268
Citation: J. Hoffmann et M. Spengler, EFFICACY OF 24-WEEK MONOTHERAPY WITH ACARBOSE, METFORMIN, OR PLACEBO IN DIETARY-TREATED NIDDM PATIENTS - THE ESSEN-II STUDY, The American journal of medicine, 103(6), 1997, pp. 483-490
Citation: J. Lindstrom et al., THE EFFECT OF ACARBOSE ON DIETARY NUTRIENT INTAKE AND METABOLIC CONTROL IN NIDDM PATIENTS, Diabetologia, 39, 1996, pp. 739-739
Citation: J. Hoffmann et M. Spengler, EFFICACY OF 24-WEEK MONOTHERAPY WITH ACARBOSE, METFORMIN OR PLACEBO IN NIDDM PATIENTS WITH DIETARY FAILURE, Diabetologia, 39, 1996, pp. 873-873
Citation: M. Spengler et M. Cagatay, THE USE OF ACARBOSE IN THE PRIMARY-CARE SETTING - EVALUATION OF EFFICACY AND TOLERABILITY OF ACARBOSE BY POSTMARKETING SURVEILLANCE STUDY, Clinical and investigative medicine, 18(4), 1995, pp. 325-331
Authors:
BISCHOF F
MEYERHOFF C
STERNBERG F
SPENGLER M
PFIEFFER EE
Citation: F. Bischof et al., 24-HOUR PROFILES OF BLOOD-GLUCOSE LACTATE AND INSULIN AND TISSUE GLUCOSE AND LACTATE UNDER ACARBOSE AND METFORMIN, Diabetologia, 38, 1995, pp. 198-198
Citation: E. Gellert et al., CAN DIFFERENCES BE OBSERVED IN THE SAFETY AND EFFICACY OF ACARBOSE BETWEEN ELDERLY (GREATER-THAN-OR-EQUAL-TO-65 YEARS) COMPARED TO YOUNGER NIDDM PATIENTS, Diabetes, 44, 1995, pp. 215-215
Authors:
MEYERHOFF C
BISCHOF F
STERNBERG F
SPENGLER M
PFEIFFER EF
Citation: C. Meyerhoff et al., INFLUENCE OF ACARBOSE AND METFORMIN UPON PLASMA-GLUCOSE AND LACTATE AND CONTINUOUSLY MEASURED TISSUE GLUCOSE AND LACTATE LEVELS IN TYPE-II DIABETIC-PATIENTS, Diabetes, 44, 1995, pp. 230-230
Citation: J. Hoffmann et M. Spengler, EFFICACY OF 24-WEEK MONOTHERAPY WITH ACARBOSE, GLIBENCLAMIDE, OR PLACEBO IN NIDDM PATIENTS - THE ESSEN STUDY, Diabetes care, 17(6), 1994, pp. 561-566